As of Dec 09
| +0.01 / +0.27%|
The 7 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 7.00, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +86.67% increase from the last price of 3.75.
The current consensus among 8 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.